Advanced biological and chemical discovery (ABCD): Centralizing discovery knowledge in an inherently decentralized world

被引:62
|
作者
Agrafiotis, Dimitris K.
Alex, Simson
Dai, Heng
Derkinderen, An
Farnum, Michael
Gates, Peter
Izrailev, Sergei
Jaeger, Edward P.
Konstant, Paul
Leung, Albert
Lobanov, Victor S.
Marichal, Patrick
Martin, Douglas
Rassokhin, Dmitrii N.
Shemanarev, Maxim
Skalkin, Andrew
Stong, John
Tabruyn, Tom
Vermeiren, Marleen
Wan, Jackson
Xu, Xiang Yang
Yao, Xiang
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Exton, PA 19341 USA
[2] Johnson & Johnson Pharmaceut Res & Dev, Div Janssen Pharmaceut NV, B-2340 Beerse, Belgium
[3] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
关键词
D O I
10.1021/ci700267w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We present ABCD, an integrated drug discovery informatics platform developed at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ABCD is an attempt to bridge multiple continents, data systems, and cultures using modern information technology and to provide scientists with tools that allow them to analyze multifactorial SAR and make informed, data-driven decisions. The system consists of three major components: (1) a data warehouse, which combines data from multiple chemical and pharmacological transactional databases, designed for supreme query performance; (2) a state-of-the-art application suite, which facilitates data upload, retrieval, mining, and reporting, and (3) a workspace, which facilitates collaboration and data sharing by allowing users to share queries, templates, results, and reports across project teams, campuses, and other organizational units. Chemical intelligence, performance, and analytical sophistication lie at the heart of the new system, which was developed entirely in-house. ABCD is used routinely by more than 1000 scientists around the world and is rapidly expanding into other functional areas within the J&J organization.
引用
收藏
页码:1999 / 2014
页数:16
相关论文
共 50 条
  • [21] Decentralized knowledge discovery using massive heterogenous data in Cognitive IoT
    Jha, Vidyapati
    Tripathi, Priyanka
    CLUSTER COMPUTING-THE JOURNAL OF NETWORKS SOFTWARE TOOLS AND APPLICATIONS, 2024, 27 (03): : 3657 - 3682
  • [22] Integration and visualization of biological data of the brain for the knowledge discovery
    Mineta, Katsuhiko
    Ikeo, Kazuho
    Tanaka, Yuzuru
    Gojobori, Takashi
    GENES & GENETIC SYSTEMS, 2006, 81 (06) : 460 - 460
  • [24] Knowledge discovery for advanced clinical data management and analysis
    Babic, A
    MEDICAL INFORMATICS EUROPE '99, 1999, 68 : 409 - 413
  • [25] Chemical Screening in Zebrafish for Novel Biological and Therapeutic Discovery
    Tan, Justin L.
    Zon, Leonard I.
    ZEBRAFISH: DISEASE MODELS AND CHEMICAL SCREENS, 3RD EDITION, 2011, 105 : 493 - 516
  • [26] Integration of chemical and biological data in discovery informatics.
    Hartsough, DS
    Gschwend, DA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U303 - U303
  • [27] Emerging chemical and biological approaches for the preparation of discovery libraries
    Boldt, GE
    Dickerson, TJ
    Janda, KD
    DRUG DISCOVERY TODAY, 2006, 11 (3-4) : 143 - 148
  • [28] Validating Small Molecule Chemical Probes for Biological Discovery
    Vu, Victoria
    Szewczyk, Magdalena M.
    Nie, David Y.
    Arrowsmith, Cheryl H.
    Barsyte-Lovejoy, Dalia
    ANNUAL REVIEW OF BIOCHEMISTRY, 2022, 91 : 61 - 87
  • [29] Chemical screening in zebrafish for novel biological and therapeutic discovery
    Wiley, D. S.
    Redfield, S. E.
    Zon, L. I.
    ZEBRAFISH: DISEASE MODELS AND CHEMICAL SCREENS, 2017, 138 : 651 - 679
  • [30] Stereocontrolled Synthesis of Spiroketals: An Engine for Chemical and Biological Discovery
    Verano, Alyssa L.
    Tan, Derek S.
    ISRAEL JOURNAL OF CHEMISTRY, 2017, 57 (3-4) : 279 - 291